文献速递毛发、甲与色素性疾病

大肠杆菌丰度与代谢与白癜风疾病活动度相关

Escherichia Abundance and Metabolism Align with Vitiligo Disease Activity.
PubMed 文献 · J Invest Dermatol · 2025-02-19

本研究比较了哈萨克斯坦和美国白癜风患者与健康对照的饮食及肠道微生物组。活动期白癜风患者特定脂肪酸、氨基酸、纤维和锌摄入有限,且肠道中Odoribacter和Escherichia丰度与疾病活动度相关,代谢通路分析支持Escherichia属通过限制能量代谢和氨基酸生物合成途径参与疾病活动,活动度还与外周促炎细胞因子升高一致。

要点

  • 活动期白癜风患者特定脂肪酸、氨基酸、纤维和锌摄入有限。
  • 肠道Odoribacter和Escherichia丰度与白癜风疾病活动度相关。
  • Escherichia属可能通过限制能量代谢和氨基酸合成参与疾病活动。

核心结论

  • 活动期白癜风患者存在特定营养摄入限制,且肠道微生物组组成与代谢通路与疾病活动度相关。
  • 营养限制未被肠道微生物代谢物补偿,可能促进炎症并加重白癜风。

研究设计与样本

  • 研究纳入来自哈萨克斯坦和美国的白癜风患者与健康对照,分析饮食和肠道微生物组组成。
  • 饮食营养摄入采用美国国立卫生研究院生成的饮食历史问卷进行评估。

主要发现

  • 活动期白癜风患者 exhibit 特定脂肪酸、氨基酸、纤维和锌的摄入有限。
  • 疾病活动度与肠道中Odoribacter和Escherichia的丰度相关。
  • 代谢通路分析支持Escherichia属通过限制能量代谢和氨基酸生物合成途径参与疾病活动。
  • 疾病活动度还与外周促炎细胞因子升高一致。

临床怎么用

  • 饮食和肠道微生物组可能作为白癜风管理的潜在干预靶点。
  • 针对活动期患者可关注特定脂肪酸、氨基酸、纤维和锌的摄入评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vitiligo is a cutaneous autoimmune disorder characterized by progressive depigmentation due to melanocyte destruction by cytotoxic T cells. Genetic factors predispose patients to the disease and are supported by environmental factors that often initiate new disease episodes. We investigated whether disease outcomes were partially defined by pathogenic microbes that drive nutrient deficiency and inflammation. Our study presents the results of research on the diet and gut microbiome composition of patients with vitiligo and healthy controls from Kazakhstan and the United States. Dietary nutrient intake was assessed using the National Institutes of Health-generated Diet History Questionnaire. Patients with active vitiligo exhibit a limited intake of specific fatty acids, amino acids, fiber, and zinc. Disease activity was further characterized by the abundance of Odoribacter and Escherichia in the gut. Metabolic pathway analysis supported the role of the Escherichia genus in disease activity by limiting energy metabolism and amino acid biosynthetic pathways. Disease activity also aligned with elevated circulating pro-inflammatory cytokines. These findings suggest that nutritional limitations are not compensated by metabolites from the gut microbiome in active disease, potentially leaving room for inflammation and exacerbating vitiligo. The intricate relationship among diet, gut microbiome composition, and disease progression in vitiligo highlights potential avenues for targeted interventions to reduce autoimmune activity and improve patient outcomes.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Mukhatayev Z, Kovenskiy A, Ren Z, et al. Escherichia Abundance and Metabolism Align with Vitiligo Disease Activity. J Invest Dermatol. 2025. PMID: 39983982. doi:10.1016/j.jid.2025.01.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。